Results 161 to 170 of about 21,294 (218)

Lung adenocarcinoma with EGFR 19Del and an ALK rearrangement benefits from alectinib instead of an EGFR-TKI: A case report. [PDF]

Medicine (Baltimore), 2022
Wang H, Zhu S, Li Z, Qi X, Zhang L, Ke L, Lin Y.   +6 more
europepmc   +1 more source

ALK Rearrangement Analysis Was Performed [PDF]

, 2020
openaire   +1 more source

Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC). [PDF]

J Exp Clin Cancer Res, 2023
Lee SY, Cho HJ, Choi J, Ku B, Moon SW, Moon MH, Kim KS, Hyun K, Kim TJ, Sung YE, Hwang Y, Lee E, Ahn DH, Choi JY, Lim JU, Park CK, Kim SW, Kim SJ, Koo IS, Jung WS, Lee SH, Yeo CD, Lee DW.   +22 more
europepmc   +1 more source

Development of a novel ALK rearrangement screening test for non-small cell lung cancers. [PDF]

PLoS One, 2021
Chen YL, Chen WL, Cheng YC, Lin MC, Yang SC, Tsai HW, Lin CC, Su WC, Chow NH, Ho CL.   +9 more
europepmc   +1 more source

ALK rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report. [PDF]

Diagn Pathol, 2022
Kai K, Tobu S, Kido S, Mikami S, Takeuchi K, Dobashi A, Togashi Y, Noguchi M, Aishima S.   +8 more
europepmc   +1 more source

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer. [PDF]

Front Pharmacol, 2023
Hu H, Tan S, Xie M, Guo P, Yu Q, Xiao J, Zhao K, Liao Q, Wang Y.   +8 more
europepmc   +1 more source

Comparison of the efficacy based on clinicopathological characteristics and the safety of first-line treatments for patients with advanced ALK rearrangement non-small cell lung cancer: a network meta-analysis. [PDF]

Front Oncol
Li Y, Wen Y, Zhang W, Zhao Y, Zhou L, Zeng X, Kang X, Li L.   +7 more
europepmc   +1 more source

Case Report: A Pregnant Woman Diagnosed as ALK-Rearrangement Lung Large Cell Neuroendocrine Cancer With Brain Metastasis. [PDF]

Front Oncol, 2022
Fu Z, Zhu G, Wang L, Hu S, Cheng L, Liu F.   +5 more
europepmc   +1 more source

Diagnostic accuracy of circulating tumor DNA for detection of ALK rearrangement in lung cancer: A systematic review and meta-analysis of 14 studies. [PDF]

PLoS One
Sun J, Yang L, Liu D, Xue H, Tian P, Li L.   +5 more
europepmc   +1 more source

ALK Rearrangement-Positive Pancreatic Cancer with Brain Metastasis Has Remarkable Response to ALK Inhibitors: A Case Report. [PDF]

Front Oncol, 2021
Ou K, Liu X, Li W, Yang Y, Ying J, Yang L.   +5 more
europepmc   +1 more source